These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 5341006)

  • 1. The time course of action of single doses of diazepam, chlorpromazine and some barbiturates as measured by auditory flutter fusion and visual flicker fusion thresholds in man.
    Besser GM; Duncan C
    Br J Pharmacol Chemother; 1967 Jun; 30(2):341-8. PubMed ID: 5341006
    [No Abstract]   [Full Text] [Related]  

  • 2. Auditory flutter fusion as a measure of the actions of centrally acting drugs: modification of the threshold for fusion and the influence of adapting stimuli.
    Besser GM
    Br J Pharmacol Chemother; 1967 Jun; 30(2):329-40. PubMed ID: 6036413
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of drugs on perception in man.
    Malitz S; Kanzler M
    Res Publ Assoc Res Nerv Ment Dis; 1970; 48():35-53. PubMed ID: 4917959
    [No Abstract]   [Full Text] [Related]  

  • 4. Time course of action of diazepam.
    Besser GM
    Nature; 1967 Apr; 214(5086):428. PubMed ID: 5340339
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of the auditory flutter fusion threshold by centrally acting drugs in man.
    Besser GM; Duncan C; Quilliam JP
    Nature; 1966 Aug; 211(5050):751. PubMed ID: 5962119
    [No Abstract]   [Full Text] [Related]  

  • 6. [Continuing flicker fusion research with sedatives including fenemal].
    Holmberg G; Livstedt B
    Nord Psykiatr Tidsskr; 1971; 25(4):391-400. PubMed ID: 4949346
    [No Abstract]   [Full Text] [Related]  

  • 7. Some observations on centrally-acting drugs in man.
    Turner P
    Proc R Soc Med; 1965 Nov; 58(11 Part 1):913-4. PubMed ID: 5322033
    [No Abstract]   [Full Text] [Related]  

  • 8. [The influence of centrally acting drugs on flicker fusion frequency].
    von Littrow C; Feller K; Graupner K; Kálmán E
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():54-7. PubMed ID: 829636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A pharmacologic analysis of the neural mechanisms of differentiating tonal and speech signals under noisy conditions].
    Traugott NN; Kaufman DA; Balonov LIa
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1968; 18(1):45-52. PubMed ID: 5745219
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of diazepam, chlorpromazine and amobarbital on the contingent negative variation.
    Kuda K
    Folia Psychiatr Neurol Jpn; 1977; 31(1):77-87. PubMed ID: 558950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diazepam and chlorpromazine on memory functions in man.
    Liljequist R; Linnoila M; Mattila MJ
    Eur J Clin Pharmacol; 1978 Jul; 13(5):339-43. PubMed ID: 352709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological analysis of EEG desynchronization reactions to afferent stimuli in man.
    Traugott NN; Bagrov YY; Balonov LY; Deglin VL; Kaufman DA; Lichko AE
    Electroencephalogr Clin Neurophysiol; 1969 May; 26(5):549. PubMed ID: 4181499
    [No Abstract]   [Full Text] [Related]  

  • 13. Interference of barbiturates with pyrimidine incorporation. II. Structural specificity of the inhibition of orotate uptake in Bacillus cereus.
    Mandel HG; Riis M
    Biochem Pharmacol; 1970 Jun; 19(6):1867-77. PubMed ID: 4398023
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbon monoxide and phenobarbitone: a comparison of effects on auditory flutter fusion threshold and critical flicker fusion threshold.
    Guest AD; Duncan C; Lawther PJ
    Ergonomics; 1970 Sep; 13(5):587-94. PubMed ID: 4923396
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychophysical profiles differentiate drugs of abuse.
    Hienz RD; Brady JV
    NIDA Res Monogr; 1981 Feb; 34():226-31. PubMed ID: 6783937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in the central actions of phenytoin and phenobarbitone in man, measured by critical flicker fusion threshold.
    Houghton GW; Latham AN; Richens A
    Eur J Clin Pharmacol; 1973 Jun; 6(1):57-60. PubMed ID: 4587516
    [No Abstract]   [Full Text] [Related]  

  • 17. [The influence of centrally acting drugs on directional hearing of normal subjects in a free acoustic field].
    Preibisch-Effenberger R; Schmidt V
    Z Laryngol Rhinol Otol; 1968 May; 47(5):377-89. PubMed ID: 5658852
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal and neonatal elimination of amobarbital after treatment of the mother with barbiturates during late pregnancy.
    Draffan GH; Dollery CT; Davies DS; Krauer B; Williams FM; Clare RA; Trudinger BJ; Darling M; Sertel H; Hawkins DF
    Clin Pharmacol Ther; 1976 Mar; 19(3):271-5. PubMed ID: 1261165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of fluphenazine and chlorpromazine on critical flicker fusion frequency.
    Turner P
    J Pharm Pharmacol; 1966 Dec; 18(12):836. PubMed ID: 4381675
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of barbiturates on the decerebrate rigidity in rats.
    Goto M; Kondo M; Fukuda H
    J Pharmacobiodyn; 1982 Sep; 5(9):643-52. PubMed ID: 7153837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.